CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award | +10,565 | 3,415,958 | ||
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy)uy) | +31,695 | 31,695 | ||
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +31,695 | 31,695 | ||
| 2025-01-07 | Ho Carole Chief Medical Officer | Sale | −2,907 | $20.81 | $60K | 175,673 |
| 2025-01-07 | Schuth Alexander O. COFO and Secretary | Sale | −2,907 | $20.81 | $60K | 244,308 |
| 2025-01-07 | Watts Ryan J. President and CEO | Sale | −7,650 | $20.81 | $159K | 253,071 |
| 2025-01-07 | Krognes Steve E. Director | Sale | −3,339 | $20.81 | $69K | 25,757 |
| 2025-01-06 | Ho Carole Chief Medical Officer | Sale | −12,255 | $20.22 | $248K | 178,580 |
| 2025-01-06 | Schuth Alexander O. COFO and Secretary | Sale | −12,255 | $20.22 | $248K | 247,215 |
| 2025-01-06 | Watts Ryan J. President and CEO | Sale | −29,266 | $20.22 | $592K | 260,721 |
| 2025-01-03 | Watts Ryan J. President and CEO | Grant or award | +54,180 | 289,987 | ||
| 2025-01-03 | Watts Ryan J. President and CEO | Grant or award · Stock Option (right to buy) | +162,540 | 162,540 | ||
| 2025-01-03 | Schuth Alexander O. COFO and Secretary | Grant or award | +54,180 | 259,470 | ||
| 2025-01-03 | Schuth Alexander O. COFO and Secretary | Grant or award · Stock Option (right to buy) | +162,540 | 162,540 | ||
| 2025-01-03 | Ho Carole Chief Medical Officer | Grant or award | +54,180 | 190,835 | ||
| 2025-01-03 | Ho Carole Chief Medical Officer | Grant or award · Stock Option (right to buy) | +162,540 | 162,540 | ||
| 2025-01-02 | SATO VICKI L Director | Sale 10b5-1 | −3,080 | $20.91 | $64K | 107,976 |
| 2024-12-31 | Krognes Steve E. Director | Sale 10b5-1 | −30,000 | $20.25 | $608K | 29,096 |
| 2024-12-27 | Schuth Alexander O. COFO and Secretary | Option exercise | +6,708 | $5.28 | $35K | 205,290 |
| 2024-12-27 | Schuth Alexander O. COFO and Secretary | Option exercise · Stock Option (right to buy) | −6,708 | 46,671 |
Page 4 of 53 · 1,043 trades